The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

被引：0
|
作者：
Obertynska, O. [1 ]
Rasputina, L. [1 ]
机构：
[1] Natl Pirogov Mem Med Univ, Vinnitsa, Ukraine
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1055
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
    Hyue Mee Kim
    In-Chang Hwang
    Wonsuk Choi
    Yeonyee E. Yoon
    Goo-Yeong Cho
    Scientific Reports, 11
  • [42] The effect of SGLT2 inhibitors treatment on left ventricular function and heart failure hospitalization in heart failure patients with reduce ejection fraction: A retrospective study
    Ramli, S. A. S.
    Ismail, A. F.
    Isa, W. Y. H. W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [43] Ivabradine In Adults with Chronic Heart Failure with Reduced Left Ventricular Ejection Fraction
    Perry, Caroline M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (06) : 415 - 426
  • [44] Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective study
    Derthoo, David
    Belmans, Ann
    Claes, Kathleen
    Bammens, Bert
    Ciarka, Agniezka
    Droogne, Walter
    Vanhaecke, Johan
    Van Cleemput, Johan
    Janssens, Stefan
    ACTA CARDIOLOGICA, 2013, 68 (01) : 51 - 57
  • [45] IvabradineIn Adults with Chronic Heart Failure with Reduced Left Ventricular Ejection Fraction
    Caroline M. Perry
    American Journal of Cardiovascular Drugs, 2012, 12 (6) : 415 - 426
  • [46] The Outcomes of Chronic Kidney Disease and Heart Failure with Reduced Ejection Fraction
    Ampadu, James O.
    Alkhawam, Hassan
    Mikhalkova, Deanna
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S133 - S133
  • [47] Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction
    Solonovych, A. Anastasiia
    Liashenko, A. V.
    Revenko, I. L.
    Mkhitaryan, L. S.
    Voronkov, L. G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 249 - 249
  • [48] Do background ischemic heart disease and baseline left ventricular ejection fraction affect cardiovascular efficacy of SGLT-2 inhibitors in heart failure with reduced ejection fraction?
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Kassimis, George
    Doumas, Michael
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (01) : E30 - E32
  • [49] PRELIMINARY DATA ASSESSING CHANGE IN LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS INITIATED ON SGLT2 INHIBITOR THERAPY - AN ONGOING OBSERVATIONAL STUDY
    O'Callaghan, D.
    Abboud, J.
    Doyle, R.
    Barrett, M.
    Halley, C.
    McDonald, K.
    HEART, 2022, 108 : A34 - A34
  • [50] SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?
    Lenahan, Christy McDonald
    Harrington, Deedra
    Stueben, Frances
    NURSE PRACTITIONER, 2021, 46 (07): : 30 - 37
12345